History of myeloid-derived suppressor cells
Open accessThe DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Abstract
Tumour-induced granulocytic hyperplasia is associated with tumour vasculogenesis and escape from immunity via T cell suppression. Initially, these myeloid cells were identified as granulocytes or monocytes; however, recent studies have revealed that this hyperplasia is associated with populations of multipotent progenitor cells that have been identified as myeloid-derived suppressor cells (MDSCs). The study of MDSCs has provided a wealth of information regarding tumour pathobiology, has extended our understanding of neoplastic progression and has modified our approaches to immune adjuvant therapy. In this Timeline article, we discuss the history of MDSCs, their influence on tumour progression and metastasis, and the crosstalk between tumour cells, MDSCs and the host macroenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Myeloid-derived suppressor cells (MDSCs), a heterogeneous group of immune cells from the myeloid lineage, are a major component of the immunosuppressive TME [93].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [93]
The cited source says what the claim attributes to it.
In the citing paper
“The TME is immunosuppressive, thus rendering the immune system less effective in killing cancer cells.”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Self-citationMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Goycoolea, A. (1997) · Cited by 3,615
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
Research works printed but not linked: 1
- Sonnenfeld A Leukamische reaktiones bei carcinoma Zeitschrift f Klin Med 1929 111
Cited by
Items 401–500 of 1,000
Paclitaxel nanoparticle awakens immune system to fight against cancer
Tang, W., Yang, J., Yuan, Y., Zhao, Z., Lian, Z., & Liang, G. (2017) · Nanoscale · doi:10.1039/c6nr09895a · Cited by 47
Yang, Q., Qiu, H., Xie, H., Qi, Y., Cha, H., Qu, J., Wang, M., Feng, Y., Ye, X., Mu, J., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601860 · Cited by 47
Cheng, P., Chen, X., Dalton, R., Calescibetta, A. R., So, T., Gilvary, D. L., Ward, G., Smith, V., Eckard, S. C., Fox, J. A., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.02.005 · Cited by 47
DAT and TH expression marks human Parkinson’s disease in peripheral immune cells
Gopinath, A., Mackie, P. M., Hashimi, B., Buchanan, A. M., Smith, A. R., Bouchard, R. S., Shaw, G., Badov, M., Saadatpour, L., Gittis, A. H., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00333-8 · Cited by 48
Fotsitzoudis, C., Koulouridi, A., Messaritakis, I., Konstantinidis, T., Gouvas, N., Tsiaoussis, J., & Souglakos, J. (2022) · Cancers · doi:10.3390/cancers14184394 · Cited by 46
Zeng, W., Liu, H., Mao, Y., Jiang, S., Hao, Y., Zhang, Z., Wang, M., & Zong, Z. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5673 · Cited by 48
Zhang, Y., Qu, D., Sun, J., Zhao, L., Wang, Q., Shao, Q., Kong, B., Zhang, Y., & Qu, X. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.41 · Cited by 46
Cangemi, M., Montico, B., Faè, D. A., Steffan, A., & Dolcetti, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00160 · Cited by 48
Adah, D., Yang, Y., Liu, Q., Gadidasu, K. K., Tao, Z., Yu, S., Dai, L., Li, X., Zhao, S., Qin, L., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0342-6 · Cited by 48
Zhong, L., Liu, Z., Zhou, X., Song, S., Weng, G.-Y., Wen, Y., Liu, F., Cao, D., & Liu, Y. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.06.004 · Cited by 47
Long noncoding RNA loss in immune suppression in cancer
Hu, Q., Egranov, S. D., Lin, C., & Yang, L. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107591 · Cited by 46
The functions of autophagy at the tumour‐immune interface
Luo, X., Qiu, Y., Dinesh, P., Gong, W., Jiang, L., Feng, X., Li, J., Jiang, Y., Lei, Y. L., & Chen, Q. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16331 · Cited by 46
Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
Dong, Y., Wan, Z., Gao, X., Yang, G., & Liu, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.609762 · Cited by 47
The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate Cancer
Xu, P., Wasielewski, L. J., Yang, J. C., Cai, D., Evans, C. P., Murphy, W. J., & Liu, C. (2022) · Biomedicines · doi:10.3390/biomedicines10081778 · Cited by 46
Green, K. A., Wang, L., Noelle, R. J., & Green, W. R. (2015) · Journal of Virology · doi:10.1128/jvi.00888-15 · Cited by 46
Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies
Zhang, M., Qin, H., Wu, Y. C., & Gao, Q. (2024) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2024.0192 · Cited by 51
TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide
Yang, F., Li, Y., Wu, T., Na, N., Zhao, Y., Li, W., Zhang, L., Zhang, L., Lu, J., & Zhao, Y. X. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1398-z · Cited by 47
Ibáñez-Vea, M., Zuazo, M., Gato, M., Arasanz, H., Fernández-Hinojal, G., Escors, D., & Kochan, G. T. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0492-4 · Cited by 47
Che, S. P. Y., Park, J. Y., & Stokol, T. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00261 · Cited by 48
Smirnova, O. A., Bartosch, B., Zakirova, N. F., Kochetkov, S. N., & Ivanov, A. V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041219 · Cited by 46
Spatial Mapping of Myeloid Cells and Macrophages by Multiplexed Tissue Staining
Saylor, J., Ma, Z., Goodridge, H. S., Huang, F., Cress, A. E., Pandol, S. J., Shiao, S. L., Vidal, A. C., Wu, L., Nickols, N. G., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02925 · Cited by 48
Luker, A. J., Graham, L., Smith, T. M., Camarena, C., Zellner, M. P., Gilmer, J.-J. S., Damle, S., Conrad, D. H., Bear, H. D., & Martin, R. (2020) · BMC Immunology · doi:10.1186/s12865-020-0337-5 · Cited by 53
Davidov, V., Jensen, G. L., Mai, S., Chen, S., & Pan, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01842 · Cited by 47
Efferocytosis Creates a Tumor Microenvironment Supportive of Tumor Survival and Metastasis
(2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.666 · Cited by 44
“They infiltrate developing tumors where they promote tumor vascularization [75] and disrupt major mechanisms of immunosurveillance which include antigen presentation by dendritic cells (DCs) [76] T cell activation [66, 76, 77] M1 macrophage polarization [78-80] and inhibition of NK cell cytotoxicity ([81]).”
Siddiqui, S., & Glauben, R. (2022) · Cancers · doi:10.3390/cancers14010250 · Cited by 49
Cha, H.-R., Lee, J. H., Hensel, J. A., Sawant, A., Davis, B. H., Lee, C. M., Deshane, J. S., & Ponnazhagan, S. (2016) · The Prostate · doi:10.1002/pros.23155 · Cited by 44
Lei, A., Yang, Q., Li, X., Chen, H., Shi, M., Xiao, Q., Cao, Y., He, Y., & Zhou, J. (2016) · Immunology · doi:10.1111/imm.12662 · Cited by 46
Kervarrec, T., Gaboriaud, P., Berthon, P., Zaragoza, J., Schrama, D., Houben, R., Corre, Y. L., Hainaut‐Wierzbicka, E., Aubin, F., Bens, G., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.12.029 · Cited by 47
Feng, Y., Liao, Z., Zhang, H., Xie, X., You, F., Liao, X., Wu, C., Zhang, W., Yang, H., & Liu, Y. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.139506 · Cited by 43
Lu, Y., Wang, Y., Miao, L., Haynes, M. T., Xiang, G., & Huang, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.025 · Cited by 43
Ling, Z., Yang, C. H., Tan, J., Dou, C., & Chen, Y. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03966-9 · Cited by 44
Zheng, X., Huang, Y., Li, K., Luo, R., Cai, M., & Yun, J. (2022) · Viruses · doi:10.3390/v14051017 · Cited by 46
Lim, J. U., Lee, E., Lee, S., Cho, H. J., Ahn, D. H., Hwang, Y., Choi, J. Y., Yeo, C. D., Park, C. K., & Kim, S. J. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-633 · Cited by 45
Adjuvants and myeloid-derived suppressor cells: Enemies or allies in therapeutic cancer vaccination
Fernández, A., Oliver, L., Álvarez-Arzola, R., Fernandez, L. E., Lee, K. P., & Mesa, C. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29847 · Cited by 43
Wang, Y., Song, W., Hu, M., An, S., Xu, L., Li, J., Kinghorn, K., Liu, R., & Huang, L. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201802847 · Cited by 44
Ghouse, S. M., Vadrevu, S. K., Manne, S., Reese, B., Patel, J., Patel, B. B., Silwal, A., Lodhi, N., Paterson, Y. Y. W., Srivastava, S., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901208 · Cited by 43
Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
Kapor, S., & Santibanez, J. F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132788 · Cited by 44
Ko, H., & Kim, Y. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0822-9 · Cited by 44
Emerging roles of Hippo signaling in inflammation and YAP-driven tumor immunity
Zhou, Y., Huang, T., Zhang, J., Cheng, A. S. L., Yu, J. Q., Kang, W., & To, K. F. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.004 · Cited by 42
Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment
Wang, D., Han, Y., Peng, L., Huang, T., He, X., Wang, J., & Ou, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79651 · Cited by 41
Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course
Coosemans, A., Decoene, J., Baert, T., Laenen, A., Kasran, A., Verschuere, T., Seys, S., & Vergote, I. B. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1111505 · Cited by 43
Zhang, H., Li, Z., Wang, L., Tian, G., Tian, J., Yang, Z., Cao, G., Zhou, H. Y., Zhao, L., Wu, Z., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00129 · Cited by 42
Ma, M., Huang, W. J., & Kong, D. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.04.013 · Cited by 44
Tumor self-responsive upconversion nanomedicines for theranostic applications
Xu, J., Gulzar, A., Yang, D., Gai, S., He, F., & Yang, P. (2019) · Nanoscale · doi:10.1039/c9nr06450h · Cited by 42
The mycobiota of the human body: a spark can start a prairie fire
Zhang, D., Wang, Y., Shen, S., Hou, Y., Chen, Y., & Wang, T. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1731287 · Cited by 44
Implications of metabolism-driven myeloid dysfunctions in cancer therapy
Strauss, L., Guarneri, V., Gennari, A., & Sica, A. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00556-w · Cited by 43
The Role of Complement in Angiogenesis
Markiewski, M. M., Daugherity, E. A., Reese, B., & Karbowniczek, M. (2020) · Antibodies · doi:10.3390/antib9040067 · Cited by 44
The role of myeloid‐derived suppressor cells in gastrointestinal cancer
Cui, C., Lan, P., & Fu, L. (2021) · 癌症:英文版 · doi:10.1002/cac2.12156 · Cited by 42
The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
Demosthenous, C., Sakellari, I., Douka, V., Papayanni, P. G., Anagnostopoulos, Α., & Gavriilaki, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102050 · Cited by 42
Gangliosides Drive the Tumor Infiltration and Function of Myeloid-Derived Suppressor Cells
Wondimu, A., Liu, Y., Su, Y. A., Bobb, D., Ma, J. S. Y., Chakrabarti, L., Radoja, S., & Ladisch, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0927 · Cited by 41
Myeloid-Derived Suppressor–Cell Dynamics Control Outcomes in the Metastatic Niche
Kreger, J., Torres, E. T. R., & MacLean, A. L. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0617 · Cited by 43
Su, Q., Zhang, B., Zhang, L., Dang, T., Rowley, D. R., Ittmann, M., & Xin, L. (2016) · Oncogene · doi:10.1038/onc.2016.232 · Cited by 40
Zhou, J., Donatelli, S. S., Gilvary, D. L., Tejera, M. M., Eksioglu, E. A., Chen, X., Coppola, D., Sheng, W., & Djeu, J. Y. (2016) · Scientific Reports · doi:10.1038/srep29521 · Cited by 40
Kwak, H., Salvucci, O., Weigert, R., Martinez-Torrecuadrada, J. L., Henkemeyer, M. J., Poulos, M. G., Butler, J. M., & Tosato, G. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87848 · Cited by 41
Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation
Koehn, B. H., & Blazar, B. R. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5mr1116-464r · Cited by 42
Urabe, F., Kosaka, N., Yoshioka, Y., Egawa, S., & Ochiya, T. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0176-z · Cited by 42
Li, B., Zhang, S., Huang, N., Chen, H., Wang, P., Yang, J. J., & Li, Z. (2018) · Oncology Reports · doi:10.3892/or.2018.6809 · Cited by 41
Myeloid‐derived suppressor cells and tumor: Current knowledge and future perspectives
Safari, E., Ghorghanlu, S., Ahmadi‐khiavi, H., Mehranfar, S., Rezaei, R., & Motallebnezhad, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27923 · Cited by 41
Ren, W., Zhang, X., Li, W., Feng, Q., Feng, H., Tong, Y., Rong, H., Wang, W., Zhang, D., Zhang, Z., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64841-4 · Cited by 41
Role of myeloid-derived suppressor cells in metastasis
Cole, K., Pravoverov, K., & Talmadge, J. E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09947-x · Cited by 40
Self-citationFultang, N., Li, X., Li, T., & Chen, Y. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.619253 · Cited by 43
Hepatic myeloid-derived suppressor cells in cancer
Medina‐Echeverz, J., Eggert, T., Han, M., & Greten, T. F. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1736-y · Cited by 44
Myeloid-derived suppressor cells in gliomas
Gieryng, A., & Kaminska, B. (2016) · Współczesna Onkologia · doi:10.5114/wo.2016.64592 · Cited by 43
Zhong, H., Zhou, S., Yin, S., Qiu, Y., Liu, B., & Yu, H. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.014 · Cited by 45
CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma
Stahl, D. J., Gödel, P., Balke‐Want, H., Gholamipoorfard, R., Segbers, P., Tetenborg, L., Koker, M., Dörr, J., Gregor, L., Bachurski, D., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.05.013 · Cited by 44
The Unfolded Protein Response in Homeostasis and Modulation of Mammalian Immune Cells
Martins, A. S., Alves, I., Helguero, L. A., Domingues, M. R., & Neves, B. M. (2016) · International Reviews of Immunology · doi:10.3109/08830185.2015.1110151 · Cited by 42
Wang, S.-H., Lu, Q., Guo, Y., Song, Y., Liu, P., & Wang, Y. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.08.019 · Cited by 41
Xing, Z., Zuo, Z., Hu, D., Zheng, X., Wang, X., Yuan, L., Zhou, L., Qi, F., & Yao, Z. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.015 · Cited by 39
Li, X., Li, Y., Yu, Q., Qian, P., Huang, H., & Lin, Y. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.1mr0421-597rr · Cited by 41
Metallic Nanoparticles for the Modulation of Tumor Microenvironment; A New Horizon
Shariatzadeh, S., Moghimi, N., Khalafi, F., Shafiee, S., Mehrabi, M., Ilkhani, S., Tosan, F., Nakhaei, P., Alizadeh, A. M., Varma, R. S., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.847433 · Cited by 43
Salem, B., Miner, S., Hensel, N. F., Battiwalla, M., Keyvanfar, K., Stroncek, D. F., Gee, A. P., Hanley, P. J., Bollard, C. M., Ito, S., et al. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.08.008 · Cited by 37
Innate immune cells: Key players of orchestra in modulating tumor microenvironment (TME)
Sadeghi, M., Dehnavi, S., Sharifat, M., Amiri, A. M., & Khodadadi, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27480 · Cited by 40
Hu, T., Zhai, J., Yang, Z., Peng, J., Wang, C., Liu, X., Li, Y., Yao, J., Chen, F., Li, H., et al. (2025) · MedComm · doi:10.1002/mco2.70231 · Cited by 40
Regulatory T-Cell Therapy for Graft-versus-host Disease.
Heinrichs, J. L., Bastian, D. A., Veerapathran, A., Anasetti, C., Betts, B., & Yu, X. (2016) · PubMed · Cited by 44
Human monocytic myeloid‐derived suppressor cells impair B‐cell phenotype and function in vitro
Jaufmann, J., Lelis, F., Teschner, A. C., Fromm, K., Rieber, N. P., Hartl, D., & Beer‐Hammer, S. (2019) · European Journal of Immunology · doi:10.1002/eji.201948240 · Cited by 38
Crosstalk between myeloid-derived suppressor cells and the immune system in prostate cancer
Sanaei, M., Salimzadeh, L., & Bagheri, N. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ru0819-150rr · Cited by 39
Hassan, G., & Seno, M. (2020) · Cells · doi:10.3390/cells9051293 · Cited by 43
Qi, J., Tang, X., Li, W., Chen, W., Yao, G., & Sun, L. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01837-x · Cited by 39
Koushki, K., Salemi, M., Miri, S. M., Arjeini, Y., Keshavarz, M., & Ghaemi, A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112346 · Cited by 42
YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango
Matthaios, D., Tolia, M., Mauri, D., Kamposioras, K. V., & Karamouzis, M. V. (2021) · Biomedicines · doi:10.3390/biomedicines9121949 · Cited by 39
Spleen-targeted nanosystems for immunomodulation
Wang, F., Lou, J., Gao, X., Zhang, L., Sun, F., Wang, Z., Ji, T., & Qin, Z. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101943 · Cited by 40
Bian, Z., Shi, L., Venkataramani, M., Abdelaal, A. M., Culpepper, C. D., Kidder, K., Liang, H., Zen, K., & Liu, Y. (2017) · European Journal of Immunology · doi:10.1002/eji.201746976 · Cited by 38
Ping-Pong—Tumor and Host in Pancreatic Cancer Progression
Mu, W., Wang, Z., & Zöller, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01359 · Cited by 38
Physical activity delays accumulation of immunosuppressive myeloid-derived suppressor cells
Garritson, J. D., Krynski, L. M., Simon, L. H., Haughian, J. M., Pullen, N., & Hayward, R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234548 · Cited by 40
Wang, R., Wang, X., Yang, S., Xiao, Y., Yanhui, J., Zhong, J., Gao, Q., & Zhang, X. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.07.009 · Cited by 37
Zhang, M., Wang, L., Liu, W., Wang, T., Sanctis, F. D., Lifang, Z., Zhang, G., Cheng, J. G., Cao, Q., Zhou, J., et al. (2022) · Journal of Immunology Research · doi:10.1155/2022/2253436 · Cited by 42
Tumor-Induced Myeloid-Derived Suppressor Cells
Sanctis, F. D., Bronte, V., & Ugel, S. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0016-2015 · Cited by 39
Lacotte, S., Slits, F., Orci, L. A., Meyer, J., Oldani, G., Delaune, V., Gonelle-Gispert, C., Morel, P., & Toso, C. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1234565 · Cited by 35
Siwaponanan, P., Siegers, J. Y., Ghazali, R., Ng, T., McColl, B., Ng, G. Z., SUTTON, P. R. N., Wang, N., Ooi, I., Thiengtavor, C., et al. (2017) · Blood · doi:10.1182/blood-2016-07-730135 · Cited by 40
Wang, Y., Liu, Y., Shu, C., Wan, J., Shan, Y., Zhi, X., Sun, L., Yi, H., Yang, Y., & He, J. (2018) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2018.05.002 · Cited by 37
Epigenetic mechanisms of tumor resistance to immunotherapy
Arenas-Ramirez, N., Sahin, D., & Boyman, O. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2908-7 · Cited by 36
Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances
Xie, D., Liu, Y., Xu, F., Dang, Z., Li, M., Zhang, Q., & Dang, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1581098 · Cited by 41
Baker, G. J., Chockley, P. J., Zamler, D. B., Castro, M. G., & Lowenstein, P. R. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1163461 · Cited by 36
Li, Z., Hu, Y., Wang, Y., Huang, X.-B., Xu, Y., Shen, Y., & Cao, J. (2017) · Infection and Immunity · doi:10.1128/iai.01020-16 · Cited by 36
Complementing Cancer Metastasis
Kochanek, D. M., Ghouse, S. M., Karbowniczek, M., & Markiewski, M. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01629 · Cited by 38
Translation of cancer immunotherapy from the bench to the bedside
Guo, Q., Huang, F., Gonçalves, C., Rincon, S. V. D., & Miller, W. H. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.001 · Cited by 41
CD86-based analysis enables observation of bona fide hematopoietic responses
Kanayama, M., Izumi, Y., Yamauchi, Y., Kuroda, S., Shin, T., Ishikawa, S., Sato, T., Kajita, M., & Ohteki, T. (2020) · Blood · doi:10.1182/blood.2020004923 · Cited by 37
Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells
Domagala, M., Laplagne, C., Leveque, E., Laurent, C., Fournié, J., Espinosa, É., & Poupot, M. (2021) · Cancers · doi:10.3390/cancers13020165 · Cited by 38
Soler, D. C., Young, A. B., Fiessinger, L., Galimberti, F., Debanne, S. M., Groft, S. G., McCormick, T. S., & Cooper, K. D. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.12.036 · Cited by 38
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.06.005 · Cited by 36
Metadata
- Authors
- Talmadge, J. E., & Gabrilovich, D. I.
- Affiliations
- University of Nebraska Medical Center (US)
- The Wistar Institute (US)
- Corresponding author
- Talmadge, James E.
- Venue
- Nature Reviews Cancer
- Published
- 2013-09-24
- Volume
- 13
- Issue
- 10
- Pages
- 739-752
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4358792
- OpenAlex
- W2122403898
- Cited by
- 1,148
- References
- 197
- Citations by year
- 2026: 29 · 2025: 57 · 2024: 80 · 2023: 74 · 2022: 105 · 2021: 132 · 2020: 110 · 2019: 95 · 2018: 101 · 2017: 90 · 2016: 129 · 2015: 93 · 2014: 43 · 2013: 7
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA084488, R01CA100062)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- myeloid-derived suppressor cells, tumor microenvironment, T cell suppression, immune evasion, tumor progression, metastasis, multipotent progenitors
- MeSH terms
- Animals, Antigens, Differentiation, Antigens, Neoplasm, Cell Differentiation, Cell Biology, Hematopoiesis, Extramedullary, Humans, Leukemoid Reaction, Medical Oncology, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Chemokines, Cell Lineage, Tumor Escape, Hematopoietic Stem Cell Mobilization, Myeloid Cells, Myeloid Progenitor Cells, Multipotent Stem Cells, Tumor Burden, History, 20th Century, History, 21st Century, Mice, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.